Getting the green light to begin clinical development is a major milestone for any injectable molecule. It’s the time when an API becomes a human-ready drug product.​  

It’s also the point at which drug owners trade benchtop exploration for market readiness rigor: well-controlled processes, cGMP requirements, regulatory expectations, and more. Preparing for these new priorities is an essential part of entering a Phase I clinical trial.​  

In this webcast, clinical manufacturing experts who have supported over 150 companies and 300 compounds will share their best planning practices how to navigate this critical transition and successfully, unlocking a new development phase for your products.​  

Watch this on-demand version of our webcast to find out how you can make the transition from pre-clinical to clinical development as efficient and smooth as possible.​